Aprea Therapeutics
在场
Aprea Therapeutics 是一家在股票代码 APRE (SE) 下上市的公司。
高管
查看带有其 12 名主要高管的组织结构图
Aprea Therapeutics 搜索最多的简介
高管在Aprea Therapeutics变化
- Nadeem Mirza已作为Chief Medical Officer加入公司 (新闻发布的2024五月3号).
创建提醒
跟踪 Aprea Therapeutics 的高管变动
药店
Aprea Therapeutics 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Aprea Therapeutics 的最新新闻稿
- Aprea Therapeutics Presents Preliminary Findings on Oral WEE1 Inhibitor APR-1051 at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics | Aprea Therapeutics
- Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit | Aprea Therapeutics
- Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics | Aprea Therapeutics
- Aprea Therapeutics to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 | Aprea Therapeutics
- Aprea Therapeutics to Present at the Life Sciences Investor Forum on September 19 | Aprea Therapeutics
- Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference | Aprea Therapeutics
- https://x.com/APRE_News
- Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference | Aprea Therapeutics
- Aprea Therapeutics Launches Disease Awareness Website for Healthcare Professionals, p53reactivation.com | Aprea Therapeutics
- Aprea Therapeutics Receives OK from FDA to Initiate Phase 1 Clinical Studies for Next-Generation Mutant p53 Reactivator, APR-548 | Aprea Therapeutics
- View more press releases Close
通过电子邮件
